ArticleBlood vessels, thrombosis & hemostasis2024

Tailoring caplacizumab administration using ADAMTS13 activity for immune-mediated thrombotic thrombocytopenic purpura.

Sean G Yates et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.